Complement system in coronary heart disease: a review.
Gardinali
M
M
Istituto di Medicina Interna, IRCCS Ospedale Maggiore, Università di Milano, Italy.
Conciato
L
L
Cafaro
C
C
Agostoni
A
A
D000706:Anaphylatoxins / Q000494:pharmacology; D000787:Angina Pectoris / Q000097:blood; D000818:Animals; D003167:Complement Activation / Q000187:drug effects; D003165:Complement System Proteins / Q000502:physiology*; D003326:Coronary Circulation / Q000187:drug effects; D003327:Coronary Disease / Q000097:blood* / Q000503:physiopathology; D004195:Disease Models, Animal; D004546:Elapid Venoms / Q000494:pharmacology; D005343:Fibrinolytic Agents / Q000494:pharmacology; D006801:Humans; D009203:Myocardial Infarction / Q000097:blood / Q000517:prevention & control; D015428:Myocardial Reperfusion Injury / Q000097:blood
D000706:Anaphylatoxins; D004546:Elapid Venoms; D005343:Fibrinolytic Agents; C016310:cobra venom factor; D003165:Complement System Proteins